Involvement of virulence properties and antibiotic resistance in Escherichia coli strains causing pyelonephritis in children
Jazyk angličtina Země Spojené státy americké Médium print-electronic
Typ dokumentu časopisecké články, práce podpořená grantem
- MeSH
- bakteriální léková rezistence MeSH
- dítě MeSH
- dospělí MeSH
- Escherichia coli účinky léků patogenita MeSH
- faktory virulence genetika fyziologie MeSH
- kojenec MeSH
- lidé MeSH
- mladiství MeSH
- předškolní dítě MeSH
- pyelonefritida mikrobiologie MeSH
- Check Tag
- dítě MeSH
- dospělí MeSH
- kojenec MeSH
- lidé MeSH
- mladiství MeSH
- mužské pohlaví MeSH
- předškolní dítě MeSH
- ženské pohlaví MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
- Názvy látek
- faktory virulence MeSH
A total of 145 Escherichia coli strains causing pyelonephritis in children were investigated for the prevalence of genes encoding the following virulence factors (VFs): P fimbria (67.6 %), S fimbria (53.8 %), AFA adhesins (2.8 %), cytotoxic necrotizing factor 1 (37.9 %), α-hemolysin (41.4 %), and aerobactin (71.7 %). One hundred and thirty-six (93.8 %) isolates harbored at least one of the virulence genes detected in the present study. Statistically significant co-occurrent presence of two VF genes was found for α-hly-cnf1, α-hly-sfa, cnf1-sfa (p<0.001), and α-hly-pap (p=0.001). Twenty-six profiles of VF genes were detected in this study. The combinations of aer-pap and aer-pap-sfa-α-hly-cnf1 were presented with the highest frequency-both of them in 28 isolates (19.3 %). All E. coli strains included in the study were susceptible to meropenem, amikacin, and tobramycin; the highest frequency resistance was found toward ampicillin (43.4 %), piperacillin (31.7 %), tetracycline (15.9 %), and trimethoprim/sulfamethoxazole (11.7 %). The resistance to the other tested antimicrobial drugs did not exceed 3 % incidence. Overall, 55.9 % strains were susceptible to all tested anti-infective agents. Antimicrobial resistance of E. coli strains toward trimethoprim/sulfamethoxazole statistically significantly correlated with the presence of α-hly (p<0.001), sfa (p<0.01), and cnf1 (p<0.05).
Zobrazit více v PubMed
J Med Microbiol. 2008 Nov;57(Pt 11):1329-1334 PubMed
Int J Med Microbiol. 2009 Jan;299(1):53-63 PubMed
Folia Microbiol (Praha). 2009;54(1):81-6 PubMed
Int J Clin Pract. 2006 Feb;60(2):170-3 PubMed
Clin Microbiol Infect. 2009 Apr;15(4):372-9 PubMed
Enferm Infecc Microbiol Clin. 2005 Apr;23(4):197-201 PubMed
J Clin Microbiol. 2006 Mar;44(3):1156-8 PubMed
J Antimicrob Chemother. 2009 Sep;64 Suppl 1:i29-36 PubMed
FEMS Immunol Med Microbiol. 1995 Oct;12(2):85-90 PubMed
Environ Microbiol Rep. 2010 Oct;2(5):628-40 PubMed
Clin Microbiol Infect. 2007 Sep;13(9):854-62 PubMed
J Antimicrob Chemother. 2002 Apr;49(4):651-9 PubMed
Foodborne Pathog Dis. 2007 Summer;4(2):134-63 PubMed
Antimicrob Agents Chemother. 2010 Mar;54(3):969-76 PubMed
Folia Microbiol (Praha). 2002;47(6):723-6 PubMed
J Clin Microbiol. 2007 Apr;45(4):1167-74 PubMed
J Clin Microbiol. 2002 Dec;40(12):4445-9 PubMed
Exp Mol Pathol. 2008 Aug;85(1):11-9 PubMed
Int J Med Microbiol. 2005 Oct;295(6-7):487-502 PubMed
Ir J Med Sci. 2005 Oct-Dec;174(4):6-9 PubMed
Clin Microbiol Infect. 2004 Jun;10(6):569-73 PubMed
J Clin Microbiol. 1987 Jan;25(1):146-9 PubMed
J Clin Microbiol. 2005 Jun;43(6):2962-4 PubMed
Int J Antimicrob Agents. 2005 Jun;25(6):550-1 PubMed
J Clin Microbiol. 2010 Apr;48(4):1099-104 PubMed
J Clin Microbiol. 2005 Dec;43(12):6064-72 PubMed
Epidemiol Mikrobiol Imunol. 2007 Aug;56(3):103-11 PubMed
Pediatr Nephrol. 2006 Mar;21(3):376-81 PubMed
